By Web Team
Boehringer Ingelheim Pharmaceuticals, Inc., and Eli Lilly and Company, makers of Tradjenta (linagliptin) and Jentadueto (linagliptin/metformin hydrochloride) tablets, recently announced the debut of My Well Planner, a free online program for adults who have Type 2 diabetes.
The program is designed to help people overcome the emotional barriers they face dealing with diabetes by offering personalized content that adjusts as participants use the tool over time. After enrolling, users are asked to complete a self-assessment that determines their motivation levels; information from this evaluation is then used to tailor the content the individual receives. The program additionally provides progress reports that can be printed out and discussed with a health-care provider.
For more information about My Well Planner, and to register, click here.
This blog entry was written by Web Editor Diane Fennell.
Source URL: https://www.diabetesselfmanagement.com/blog/free-online-program-for-type-2s/
Web Team: The Diabetes Self-Management Web Team is made up of various editorial staff members.
Disclaimer of Medical Advice: You understand that the blog posts and comments to such blog posts (whether posted by us, our agents or bloggers, or by users) do not constitute medical advice or recommendation of any kind, and you should not rely on any information contained in such posts or comments to replace consultations with your qualified health care professionals to meet your individual needs. The opinions and other information contained in the blog posts and comments do not reflect the opinions or positions of the Site Proprietor.
Copyright ©2020 Diabetes Self-Management unless otherwise noted.